Cite

HARVARD Citation

    Ohsawa, I. et al. (2021). Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial. Allergy. 76 (6), pp. 1789-1799. [Online]. 
  
Back to record